M&A, Recapitalization, and Growth Financing Advice to Drive Transformative Transactions

Crosstree serves as your vested partner to empower you — a founder, investor, or operator — to confidently connect with leading health science companies, align interests, and optimize outcomes. Working within the pharma services, diagnostics and tools, and digital health sectors, Crosstree identifies transformational trends and helps clients explore greater market insights and financial possibilities by providing objective insight to deliver the best possible outcome.



Success Rate


Strategic Buyers



Crosstree’s Client Outcomes Consistently Exceed Industry Benchmarks

Crosstree’s deep industry focus fosters efficient project execution. The company’s relationships with investors and strategic buyers are unmatched in the industry.

Crosstree’s deals consistently achieve “spike valuations” through concise articulation of client value propositions, credible financial and technical support, and thoughtful alignment of industry trends.

Crosstree’s culmination of industry expertise that leverages market data, trends, and a high-profile network, drives an outstanding closing rate of almost 90%.

By combining technology, structured project management methodology, and a focused process approach, Crosstree closes transactions faster — with less resourcing strain on clients — compared to traditional investment banks.

Recent Deals

LongueVue Capital Partners Acquires Majority Stake in Summit Clinical Research to Accelerate SMO/IRO Growth
H.I.G. Capital Acquires Majority Stake in  Navitas Life Sciences to Accelerate CRO Growth
Lexitas Acquired by NovaQuest to Support Continued Growth and Capability Expansion
Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives